Pseudopyloric Metaplasia Is Not Associated With the Development of Gastric Cancer

Emanuele Dilaghi1, Francesca Baldaro1, Emanuela Pilozzi2

  • 1Department of Medical-Surgical Sciences and Translational Medicine, Sant'Andrea Hospital, University Sapienza, Rome, Italy.

Abstract

Insights

Corpus pseudopyloric metaplasia (PPM) in atrophic gastritis (CAG) alone does not lead to gastric cancer (GC). Gastric cancer development in CAG patients requires intestinal metaplasia (IM) as a necessary precursor.

Area of Science:

  • Gastroenterology
  • Oncology
  • Pathology

Background:

  • Corpus atrophic gastritis (CAG) is a precancerous condition.
  • Intestinal metaplasia (IM) and pseudopyloric metaplasia (PPM) are common findings in CAG.
  • The independent role of corpus PPM in gastric cancer (GC) development is not well understood.

Purpose of the Study:

  • To investigate the association between corpus mucosa PPM and the incidence of GC in patients with CAG.
  • To determine if corpus PPM without concomitant IM is a risk factor for GC development.

Main Methods:

  • A longitudinal cohort study of 292 patients with CAG undergoing endoscopic-histological surveillance.
  • Patients were stratified based on the presence or absence of corpus PPM without concurrent corpus IM at baseline.
  • Gastric neoplastic lesions (GC/gastric dysplasia) were assessed at follow-up (mean 4.2 years).

Main Results:

  • Corpus PPM without IM was diagnosed in 21.2% of patients at baseline.
  • GC or gastric dysplasia occurred in 9 patients (3.1%) during follow-up.
  • All patients who developed GC/dysplasia had corpus IM at baseline and follow-up; none had isolated corpus PPM.

Conclusions:

  • Corpus PPM alone is not associated with an increased risk of GC development.
  • The presence of corpus IM is a necessary step for GC development in patients with CAG.
  • Corpus PPM without IM may indicate an earlier stage of disease progression.

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
284
Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
1.3K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
349
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
742
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
362
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
1.0K